A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
about
A genetic inference on cancer immune responsivenessThe prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis.A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferonNon-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".
P2860
A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@ast
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@en
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@nl
type
label
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@ast
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@en
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@nl
prefLabel
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@ast
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@en
A multi-factorial genetic mode ...... receiving adjuvant interferon.
@nl
P2093
P2860
P1433
P1476
A multi-factorial genetic mode ...... receiving adjuvant interferon
@en
P2093
Francesco M Marincola
Helen Gogas
John M Kirkwood
Lorenzo Uccellini
Maria Spyropoulou-Vlachou
Monica C Panelli
Yingdong Zhao
P2860
P304
P356
10.1371/JOURNAL.PONE.0040805
P407
P577
2012-07-24T00:00:00Z